Published 2021
| Version v1
Publication
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study
- Creators
- Bettiol, Alessandra
- Urban, Maria Letizia
- Dagna, Lorenzo
- Cottin, Vincent
- Franceschini, Franco
- Del Giacco, Stefano
- Schiavon, Franco
- Neumann, Thomas
- Lopalco, Giuseppe
- Novikov, Pavel
- Baldini, Chiara
- Lombardi, Carlo
- Berti, Alvise
- Alberici, Federico
- Folci, Marco
- Negrini, Simone
- Sinico, Renato Alberto
- Quartuccio, Luca
- Lunardi, Claudio
- Parronchi, Paola
- Moosig, Frank
- Espígol-Frigolé, Georgina
- Schroeder, Jan
- Kernder, Anna Luise
- Monti, Sara
- Silvagni, Ettore
- Crimi, Claudia
- Cinetto, Francesco
- Fraticelli, Paolo
- Roccatello, Dario
- Vacca, Angelo
- Mohammad, Aladdin J
- Hellmich, Bernhard
- Samson, Maxime
- Bargagli, Elena
- Cohen Tervaert, Jan Willem
- Ribi, Camillo
- Fiori, Davide
- Bello, Federica
- Fagni, Filippo
- Moroni, Luca
- Ramirez, Giuseppe Alvise
- Nasser, Mouhamad
- Marvisi, Chiara
- Toniati, Paola
- Firinu, Davide
- Padoan, Roberto
- Egan, Allyson
- Seeliger, Benjamin
- Iannone, Florenzo
- Salvarani, Carlo
- Jayne, David
- Prisco, Domenico
- Vaglio, Augusto
- Emmi, Giacomo
- Others:
- Bettiol, Alessandra
- Urban, Maria Letizia
- Dagna, Lorenzo
- Cottin, Vincent
- Franceschini, Franco
- Del Giacco, Stefano
- Schiavon, Franco
- Neumann, Thoma
- Lopalco, Giuseppe
- Novikov, Pavel
- Baldini, Chiara
- Lombardi, Carlo
- Berti, Alvise
- Alberici, Federico
- Folci, Marco
- Negrini, Simone
- Sinico, Renato Alberto
- Quartuccio, Luca
- Lunardi, Claudio
- Parronchi, Paola
- Moosig, Frank
- Espígol-Frigolé, Georgina
- Schroeder, Jan
- Kernder, Anna Luise
- Monti, Sara
- Silvagni, Ettore
- Crimi, Claudia
- Cinetto, Francesco
- Fraticelli, Paolo
- Roccatello, Dario
- Vacca, Angelo
- Mohammad, Aladdin J
- Hellmich, Bernhard
- Samson, Maxime
- Bargagli, Elena
- Cohen Tervaert, Jan Willem
- Ribi, Camillo
- Fiori, Davide
- Bello, Federica
- Fagni, Filippo
- Moroni, Luca
- Ramirez, Giuseppe Alvise
- Nasser, Mouhamad
- Marvisi, Chiara
- Toniati, Paola
- Firinu, Davide
- Padoan, Roberto
- Egan, Allyson
- Seeliger, Benjamin
- Iannone, Florenzo
- Salvarani, Carlo
- Jayne, David
- Prisco, Domenico
- Vaglio, Augusto
- Emmi, Giacomo
Description
Mepolizumab proved efficacious for eosinophilic granulomatosis with polyangiitis (EGPA, former Churg-Strauss) at the dosage of 300mg/4 weeks in the randomized controlled MIRRA trial. Few successful real-life experiences with the dosage approved for severe eosinophilic asthma (100mg/4 weeks) were recently reported. We retrospectively assessed the effectiveness and safety of mepolizumab 100 and 300mg/4 weeks in a large European EGPA cohort.
Additional details
- URL
- http://hdl.handle.net/11567/1055496
- URN
- urn:oai:iris.unige.it:11567/1055496
- Origin repository
- UNIGE